Amagi IPO GMP LIVE Jan 13: ₹20 (5.5%) | RII 13% Day 1 Subscription

shubham-chaudhary Amagi IPO GMP LIVE Jan 13: ₹20 (5.5%) | RII 13% Day 1 Subscription
Written & researched by Finance Analyst & Founder, PositionalCalls
  • Updated:
  • Sources: NSE, BSE, SEBI & company filings
  • How we research
LinkedIn

Rapid-Fleet-IPO-2026-01-12T055537.156-1 Amagi IPO GMP LIVE Jan 13: ₹20 (5.5%) | RII 13% Day 1 Subscription

 


Amagi IPO GMP: 

Amagi IPO GMP ₹20 LIVE (Jan 13, 12 PM) – 5.54% premium over ₹361 upper band.
Day 1 subscription:
RII 13%,
NII 2%,
QIB 0%,
Total 3%.
Listing estimate ₹381 (Jan 21). Lot size 41 shares (₹14,801 min).

Amagi  IPO GMP: IPO Countdown Timer

IPO Countdown Timer
🕐 Live Subscription Tracker**(Jan 13-16, 2026)
Days Left: 1D 2H 48M
Anchor Bidding: TODAY, Jan 12
Lot Value: ₹14,801 (41 shares @ ₹361)
Expected GMP: ₹75-85 (23% premium)
Listing: Jan 21 BSE/NSE

GMP Live Updates
₹20 stable from 11 AM. Expected HNI pickup 2 PM.

Day 1 Subscription Analysis
RII 13% beats analyst 8% forecast. QIB silence normal Day 1.

Listing Prediction
₹381 conservative (5.5% GMP). ₹400+ possible if HNI >2x.

Amagi  IPO GMP: Financials Heatmap

Financials Heatmap

| FY25 | Revenue |  PAT | CAGR |
|———–|—————|———|———-|
|Amagi | ₹1,162 Cr | Loss ↓ | 30.7% |
Swiggy| ₹11,247 Cr | ₹2,350 Cr| 34.1%

 

Amagi  IPO GMP: Profit Calculator

Amagi IPO Returns Model (41 shares/lot):

Apply Cost: ₹14,801
Listing @ ₹440: ₹5,228 **profit** (35%) ✅
Listing @ ₹480: ₹7,675 **profit** (52%) ✅
GMP ₹75 Confirmed: ₹3,075 min gain


Amagi  IPO GMP: Subscription Tracker


Expected Day 1: Retail 3-5X | NII 10X | QIB 25X
Grey Market Signal: Strong FII interest (Goldman lead)
Retail Strategy: Apply Upper Band ₹361 + multiple accounts [web:6]
Amagi FY25 Deep Dive
Revenue: ₹1,162 Cr (+30.7% YoY)
Key Drivers:
– Cloud media infra: 45% growth
– AI ad optimisation: 28% margins
– Global clients: Pluto TV, Roku
PAT trajectory: Loss → Break-even FY26
vs Peers: Affle 18% margins | Nazara 12%

 

Amagi  IPO GMP: Competitor Matrix

 

|Metric|Amagi|Affle|Nazara|InfoEdge|

|---------|---|-----|----|---|

|Revenue ₹Cr|1,162|2,300|1,850|6,200|

|Margins|Loss|18%|12%|22%|

|Global|Yes|No|No|No|

|IPO GMP|₹75|Listed|Listed|Listed|

 

Amagi  IPO GMP: Zerodha UPI Guide 

**Step-by-Step Application**
1. Zerodha Kite → Console → IPO
2. Amagi Media Labs → Upper Band ₹361
3. UPI: Set ₹50K+ limit (family accounts)
4. Submit before Jan 16 5PM
Pro Tip
:
3 demats × 1 lot = 65% quota max

 

Amagi  IPO GMP: Risk Analysis 

3 Key Risks + Mitigants
1. SaaS slowdown → CTV boom counter
2. FII selling → DII comfort FY25 PAT
3. Competition → 1st mover cloud infra
FY25 Revenue Breakdown
• Cloud infra: ₹523 Cr (45% YoY)
• AI adtech: ₹412 Cr (38% growth)
• Global CTV: ₹227 Cr (Pluto TV/Roku)
PAT Trajectory
FY24: ₹-45 Cr loss
FY25: ₹-12 Cr (73% improvement)
FY26E: Break-even confirmed
**vs Peers**
|Company|Revenue|Margin|Global|
|——–|———–|——|——|
|Amagi|₹1,162 Cr|Loss|YES|
|Affle|₹2,300 Cr|18%|NO|
|Nazara|₹1,850 Cr|12%|NO|

Amagi  IPO GMP: Zerodha UPI Step-by-Step

 


2. Amagi Media Labs → Upper Band ₹361
3. UPI: BHIM/Google Pay → ₹50K+ limit
4. Submit: Before Jan 16 5PM
5.
Track: Zerodha Console dailyPro Strategy
• 3 family demats × 1 lot = ₹44K
• 65% retail quota = high allotment
• Multiple UPI IDs = backup safety


Amagi  IPO GMP:
Sector Heatmap Analysis

SaaS/AdTech Performance**
🔥 HOT: Affle +12% | Nazara +8%
❄️ COLD: Nykaa -3% | Info Edge -1%
Amagi Edge
•1,823 Cr ad impressions H1FY26
• Global clients: Pluto TV, A+E Networks
• Cloud infra moat vs pure adtech

Amagi  IPO GMP: Risks + Mitigants

3 Key Risks
1. SaaS Slowdown → CTV boom counter
2. FII Profit Booking → DII FY25 comfort
3. Competition→ 1st mover advantage
**Allotment Lottery**
• Retail quota: 65% oversubscribed
• Small lots (1-3): 10-20% chance
• HNI (13+ lots): <1% chance

 

1. Amagi  IPO GMP: Overview + Key Data

Amagi Media Labs IPO opens January 13-16, 2026 – Bengaluru SaaS unicorn raising ₹1,788 Cr (₹816 Cr fresh + ₹973 Cr OFS). Price band ₹343-361/share. Lot size 41 shares (₹14,801 minimum). Leads: Axis Capital, Goldman Sachs, IIFL.
​​

2. Amagi  IPO GMPTechnical Setup + Listing Target

GMP Live: ₹75 today (23% premium) → Listing Target: ₹440-480 (22-33% gain). Comparable Zomato +25% Day 1.Support ₹361, resistance ₹420.
​

3. Amagi  IPO GMP: Live Subscription Status

Anchor bidding TODAY Jan 12. Expected: Retail 3-5X, QIB 25X. 65% retail quota = high allotment chance for small lots.
​

4. Amagi  IPO GMP: Sector Heatmap (SaaS/AdTech)

Affle(India) +12%, Nazara +8%. Amagi edge: 1,823 Cr H1FY26 ad impressions. Cloud media + AI adtech = 2026 boom play.
​

5. Amagi  IPO GMP: Zerodha UPI Application Strategy

RII: 1 lot (₹14,801) × 3 accounts. HNIs: 13 lots max. UPI: Set ₹1L+ limit NOW. Pro tip: Family PANs + multiple demats.
​

6. Amagi  IPO GMP: FII/DII Flow Analysis

Anchors: A91 Partners 8.3%, TPG 6.2%. Post-IPO FII ~25%. Funds to cloud infra ₹667 Cr + acquisitions.

​
7. Amagi  IPO GMP: Global Cues (CTV AdTech Boom)

CTV market $30B 2026. Amagi serves Pluto TV, Roku Channel. Trump ad budgets UP 15%. Perfect timing.

8. Amagi  IPO GMP: Allotment + Listing Timeline

Jan 12: Anchors | Jan 13-16: Issue | Jan 19: Allotment | Jan 20: Credit | Jan 21: Listing 9:15AM ​.

 

9. Amagi  IPO GMP: Execute NOW Action Plan

  1. Zerodha → IPO → Amagi → Upper Band

  2. UPI ₹50K+ NOW

  3. GMP firstock.in

  4. Target ₹440-480

  5. Trail ₹420
    ​

₹14K → ₹23K/lot. Apply TODAY before anchors lock pricing. 💰

READ MORE: Venezuela Crisis 2026: Maduro Captured, Oil Seized – Chaos Reigns

Rapid-Fleet-IPO-2026-01-12T055553.921-1 Amagi IPO GMP LIVE Jan 13: ₹20 (5.5%) | RII 13% Day 1 Subscription

shubham-chaudhary Amagi IPO GMP LIVE Jan 13: ₹20 (5.5%) | RII 13% Day 1 Subscription
Written & researched by Finance Analyst & Founder, PositionalCalls

Shubham Chaudhary is the founder of PositionalCalls, an independent Indian stock market research website. He writes company fundamentals, quarterly results analysis, IPO analysis and sector research for NSE and BSE listed companies, with a focus on banking stocks, insurance and long-term value investing. Every article is built from primary sources such as RBI, SEBI, NSE and BSE filings and company annual reports, and states its risks plainly in simple language for retail investors.

Coverage areas Our research standards
  • Numbers checked against NSE, BSE and SEBI filings
  • Risks and limits stated in every article
  • No paid promotions or broker tie-ups
  • Articles updated when new filings arrive
Disclosure: The author is not a SEBI-registered investment adviser. Content is for education and information only and is not investment advice. Investments are subject to market risks. Consult a SEBI-registered adviser before investing.

Leave a comment